Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 8083710

Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
1994 Sep
First author
Hussain M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hussain M
      type
      Author
    2. name
      Wolf M
      type
      Author
    3. name
      Marshall E
      type
      Author
    4. name
      Crawford ED
      type
      Author
    5. name
      Eisenberger M
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hussain M
      type
      Author
    2. name
      Wolf M
      type
      Author
    3. name
      Marshall E
      type
      Author
    4. name
      Crawford ED
      type
      Author
    5. name
      Eisenberger M
      type
      Author
    bibliography ids
    1. nci-bib-a8ddb61076b22369ad97bbac
    book metadata
    content sha256
    a68c02b17576402f4726130c2772850d7c876f37e9a0afeef6b58cc98ed930e2
    document type
    citation
    dois
    1. 10.1200/JCO.1994.12.9.1868
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:8083710
    immutable id
    pubmed:8083710@a68c02b17576402f4726130c2772850d7c876f37e9a0afeef6b58cc98ed930e2
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    Source null
    issn print
    0732-183X
    issue
    9
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    1868-75
    volume
    12
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      8083710
      provenance
      batch id
      83ec39f94a925b232876
      provider
      NCBI PubMed ESummary
      record sha256
      6faaf2cf4658a6f2f62b8718c712adfee2c82bd9a11053b7fb1daaba3724c734
      response sha256
      9cea37bf3451de6aa8c54c490de635080a496054249095b8c254be0e69164eca
      retrieved at
      2026-09-09T23:45:20.996485+00:00
      publication date
      display
      1994 Sep
      precision
      month
      year
      1994
      publication types
      1. Clinical Trial
      2. Clinical Trial, Phase II
      3. Journal Article
      4. Multicenter Study
      5. Research Support, U.S. Gov't, P.H.S.
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/8083710/
      title
      Effects of continued androgen-deprivation therapy and other prognostic factors on response and survival in phase II chemotherapy trials for hormone-refractory prostate cancer: a Southwest Oncology Group report.

      Preserved source evidence · Not medical advice